Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.84
+1.09 (16.15%)
Mar 9, 2026, 1:16 PM EDT - Market open
Solid Biosciences Employees
Solid Biosciences had 100 employees as of December 31, 2024. The number of employees increased by 12 or 13.64% compared to the previous year.
Employees
100
Change (1Y)
12
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,671,350
Market Cap
610.82M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 265 |
| Allogene Therapeutics | 229 |
| Rigel Pharmaceuticals | 164 |
| Prothena Corporation | 163 |
| Invivyd | 100 |
| Ocugen | 95 |
| Neumora Therapeutics | 95 |
| CorMedix | 65 |
SLDB News
- 3 days ago - Solid Biosciences Announces Oversubscribed $240 Million Private Placement - GlobeNewsWire
- 3 days ago - Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - GlobeNewsWire
- 6 days ago - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Solid Biosciences Inc. (SLDB) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript - Seeking Alpha
- 27 days ago - Solid Biosciences: Positive FDA Meeting For SGT-003 Sets Up Next Milestones - Seeking Alpha
- 4 weeks ago - Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy - GlobeNewsWire
- 4 weeks ago - Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 7 weeks ago - Solid Biosciences Inc. (SLDB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha